Tianyin Pharmaceutical Co. announced it received GMP certification for its new solid dosage manufacturing facility from the SFDA. The company said the new facility will triple its solid dose capacity. Tianyin, which has historically concentrated in TCM, has been branching out into generic versions of western drugs. More details...

Stock Symbol: (NYSE AMEX: TPI)